Zai Lab Limited (ZLAB)
Largest Insider Buys in Sector
ZLAB Stock Price History Chart
ZLAB Stock Performance
About Zai Lab Limited
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular …
Insider Activity of Zai Lab Limited
Over the last 12 months, insiders at Zai Lab Limited have bought $246,290 and sold $2.92M worth of Zai Lab Limited stock.
On average, over the past 5 years, insiders at Zai Lab Limited have bought $222,127 and sold $60.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smiley Joshua L (See Remarks) — $492,580.
The last purchase of 3,000 shares for transaction amount of $64,200 was made by Smiley Joshua L (See Remarks) on 2024‑05‑13.
List of Insider Buy and Sell Transactions, Zai Lab Limited
| 2024-11-04 | Sale | Chief Financial Officer | 167 0.0002% | $30.66 | $5,121 | -2.48% | ||
| 2024-10-02 | Sale | Chief Financial Officer | 301 0.0003% | $25.40 | $7,645 | +6.50% | ||
| 2024-09-03 | Sale | director | 2,500 0.0025% | $19.50 | $48,750 | +30.90% | ||
| 2024-08-19 | Sale | Chief Legal Officer | 1,924 0.0019% | $16.95 | $32,620 | +45.03% | ||
| 2024-08-16 | Sale | See Remarks | 4,352 0.0045% | $16.67 | $72,561 | +1.90% | ||
| 2024-08-15 | Sale | Chief Financial Officer | 422 0.0004% | $16.06 | $6,779 | 0.00% | ||
| 2024-08-12 | Sale | See Remarks | 3,115 0.0031% | $16.20 | $50,463 | +51.38% | ||
| 2024-07-01 | Sale | Chairperson & CEO | 7,013 0.0069% | $17.48 | $122,573 | 0.00% | ||
| 2024-07-01 | Sale | director | 10,397 0.0102% | $17.32 | $180,085 | 0.00% | ||
| 2024-06-26 | Sale | Chairperson & CEO | 23,939 0.0242% | $17.90 | $428,532 | +15.19% | ||
| 2024-06-26 | Sale | See Remarks | 7,431 0.0075% | $17.90 | $133,022 | +15.19% | ||
| 2024-06-26 | Sale | Chief Legal Officer | 5,062 0.0051% | $17.90 | $90,615 | +15.19% | ||
| 2024-06-26 | Sale | Chief Financial Officer | 2,154 0.0022% | $17.90 | $38,559 | +15.19% | ||
| 2024-05-14 | Sale | Chief Legal Officer | 10,000 0.01% | $21.33 | $213,346 | -7.56% | ||
| 2024-05-13 | See Remarks | 3,000 0.003% | $21.40 | $64,200 | -7.37% | |||
| 2024-04-04 | Sale | See Remarks | 2,105 0.0022% | $15.67 | $32,992 | +24.98% | ||
| 2024-04-04 | Sale | See Remarks | 1,988 0.002% | $15.67 | $31,158 | +24.98% | ||
| 2024-04-04 | Sale | Chief Legal Officer | 1,244 0.0013% | $15.67 | $19,497 | +24.98% | ||
| 2024-04-04 | Sale | See Remarks | 1,952 0.002% | $15.67 | $30,594 | +24.98% | ||
| 2024-04-04 | Sale | Chief Financial Officer | 845 0.0009% | $15.67 | $13,244 | +24.98% |
Insider Historical Profitability
| Smiley Joshua L | See Remarks | 43232 0.0402% | $25.76 | 4 | 2 | |
| WIRTH PETER | director | 0 0% | $25.76 | 1 | 1 | <0.0001% |
Institutional Investor Ownership
| Wellington Management Company | $106.66M | 6.68 | 6.66M | +24.76% | +$21.17M | 0.02 | |
| Capital World Investors | $91.06M | 5.71 | 5.68M | +8.92% | +$7.45M | 0.02 | |
| Janus Henderson | $70.92M | 4.45 | 4.43M | +9.6% | +$6.21M | 0.04 | |
| Woodline Partners LP | $41.6M | 2.61 | 2.6M | +28.65% | +$9.26M | 0.36 | |
| Viking Global Investors | $32.81M | 2.06 | 2.05M | +9.57% | +$2.87M | 0.01 |